GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) » Definitions » LT-Debt-to-Total-Asset

Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) LT-Debt-to-Total-Asset : 0.00 (As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is Shafa Darou Pharmaceutical Investment Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Shafa Darou Pharmaceutical Investment Co's long-term debt to total assests ratio for the quarter that ended in . 20 was 0.00.

Shafa Darou Pharmaceutical Investment Co's long-term debt to total assets ratio stayed the same from . 20 (0.00) to . 20 (0.00).


Shafa Darou Pharmaceutical Investment Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Shafa Darou Pharmaceutical Investment Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shafa Darou Pharmaceutical Investment Co LT-Debt-to-Total-Asset Chart

Shafa Darou Pharmaceutical Investment Co Annual Data
Trend
LT-Debt-to-Total-Asset

Shafa Darou Pharmaceutical Investment Co Semi-Annual Data
LT-Debt-to-Total-Asset

Shafa Darou Pharmaceutical Investment Co LT-Debt-to-Total-Asset Calculation

Shafa Darou Pharmaceutical Investment Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in . 20 is calculated as

LT Debt to Total Assets (A: . 20 )=Long-Term Debt & Capital Lease Obligation (A: . 20 )/Total Assets (A: . 20 )
=/
=

Shafa Darou Pharmaceutical Investment Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in . 20 is calculated as

LT Debt to Total Assets (Q: . 20 )=Long-Term Debt & Capital Lease Obligation (Q: . 20 )/Total Assets (Q: . 20 )
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shafa Darou Pharmaceutical Investment Co  (XTEH:SHFA1) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Shafa Darou Pharmaceutical Investment Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Shafa Darou Pharmaceutical Investment Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Fakhar Moghadam Street, Dadman Street, No. 13, At the corner of East 4th Golbarg Alley, Shahrak-e Gharb, Tehran, IRN
Shafa Darou Pharmaceutical Investment Co is a pharmaceutical holding company. Along with its subsidiaries it produces injectable, non-injectable, and antibiotics.

Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) Headlines

No Headlines